baber/WOPTO huggingface dataset:
Patent DE-69221604-D1 (DE)
Inventor: LUNDIN ARNE
IPC: C07H1/08
Filed: 1992-01-10
Granted: 1997-09-18
Abstract: A method of preparing an extract of an intracellular component, wherein cells are contacted with an extractant to generate an extract solution, which comprises contacting the solution with a cyclodextrin to neutralize the extractant. preferred extractants are cationic or other kinds of surfactants. The cyclodextrin is preferably used in solution. Preferred intracellular components are ATP which can, after neutralization of the extractant, be assayed by a firefly luciferase assay; and DNA or RNA which can, after neutralization of the surfactant, be amplified or further processed in other ways.
Patent DE-69224759-D1 (DE)
Inventor: SANYAL SUGATA
IPC: C02F3/06
Filed: 1992-11-30
Granted: 1998-04-16
Abstract: This invention relates to a process for reducing the concentration of an organic and/or inorganic pollutant in a fluid stream which comprises passing the stream through a bioreacter containing a fixed biologically active biomass comprising an effective number of open or substantially open spaces and a plurality of biologically active bodies comprising a hydrophobic polyurethane substrate having an effective amount of one or more microorganism capable of metabolizing at least one of the said pollutant on, in or on and in said substrate in the absence or in the substantial absence of an absorbent.
Patent DE-69227198-D1 (DE)
Inventor: PAYNE JEWEL
IPC: C07K14/325
Filed: 1992-12-31
Granted: 1998-11-05
Abstract: Methods and compositions for the control of lice are described. Specifically, Bacillus thuringiensis (B.t.) isolates having anti-lice activity are disclosed. Also described are recombinant hosts which express B.t. genes coding for pesticidal toxins. The B.t. isolates and recombinant proteins are shown to be useful in a method for controlling lice including the sheep louse.
Patent DE-69231241-D1 (DE)
Inventor: ONO KENCHI
IPC: G06F9/445
Filed: 1992-12-02
Granted: 2000-08-17
Abstract: An apparatus and method to put in a ready state regardless of error existence in default information. The default information read from an external storage unit is analyzed, judged whether or not the apparatus can be put in a ready stated based on the default information, and if not, the default information is invalidated and determined as error. An error skip is instructed where the error has occurred, default information is read from an internal memory or another external memory and set as default information. Furthermore, the default information can be modified so as to correspond to the current configuration. <IMAGE>
Patent DE-69231753-D1 (DE)
Inventor: SHANKAR RAVI
IPC: G06F19/00
Filed: 1992-06-11
Granted: 2001-04-26
Abstract: The present invention relates to a method for detecting the onset of atherosclerosis and for detecting the degree of atherosclerosis. Accordingly, one aspect of the present invention correlates data obtained from arteries having a measured amount of stenosis with actual arterial data (blood volume change vs. cuff pressure) obtained from a patient which is converted into data relating to the patient's arterial peak compliance. Another aspect of the present invention detects the onset and the degree of atherosclerosis by classifying the shape of a curve obtained by relating arterial blood volume change with cuff pressure. Two devices can be used, an electrical impedance plethysmograph and a volume plethysmograph.
Patent DE-69233760-D1 (DE)
Inventor: LEY ARTHUR CHARLES
IPC: C07K14/435
Filed: 1992-02-28
Granted: 2009-06-25
Abstract: The present invention relates to non-naturally occurring proteins which inhibit human neutrophile elastase, which proteins comprise at least the core sequence of a Kunitz domain. Other aspects of the invention relate to pharmaceutical compositions comprising these proteins, and the use of these proteins or compositions for use in medicine, in particular for the preparation of medicaments for the treatment of disorders or diseases associated with excessive human neutrophile elastase activity.
Patent DE-69306345-D1 (DE)
Inventor: NAKAI HISAO
IPC: C07D209/20
Filed: 1993-09-17
Granted: 1997-01-16
Abstract: Amidinophenol derivatives of the formula (I): <CHEM> wherein R<1> and R<2> are (i) H, (ii) C1-4 alkyl, (iii) C1-4 alkoxy, (iv) C2-5 acyl, (v) halogen, (vi) NO2, (vii) benzoyl, (viii) COOR<4>(in which R<4> is C1-3 alkyl); A is bond, C1-4 alkylene, -C(R<5>)=C(R<6>)- (in which R<5> and R<6> are H or C1-4 alkyl); R<3> is (i) CON(R<7>)(R<8>), (ii) CON(R<9>)-CH(R<7>)(R<8>) or (iii) <CHEM> (in which R<7> and R<8> are (1) H, (2) phenyl, (3) C7-10 phenylalkyl, (4) pheny or C7-10 phenylalkyl substituted by 1or 2 C1-4 alkyl, halogen or R<1><1>-COOR<1><2> (in which R<1><1> is bond, C1-8 alkylene, C2-8 alkenylene, C2-8 alkynylene; R<1><2> is H, C1-4 alkyl, C7-10 phenylalkyl, phenyl, allyl, propargyl), (5) C1-10 alkyl, (6) C2-10 alkenyl having 1 to 3 double bonds, (7) C2-10 alkynyl having 1 or 2 triple bonds, (8) R<11a>-COXR<1><2>(in which R<11a> is (a) bond, (b) C1-8 alkylene, (c) C2-8 alkylene in which 1 or 2 carbon atoms in the main chain are replaced by sulfur, or sulfur and phenylene, (d) C2-8 alkenylene, (e) C4-8 alkenylene in which 1 or 2 carbon atoms in the main chain are replaced by sulfur, or sulfur and phenylene, (f) C2-8 alkynylene, (g)C4-8 alkynylene in which 1 or 2 carbon atoms in the main chain are replaced by sulfur, or sulfur and phenylene; X is -O- or -NH-), (9) C1-4 alkyl substituted by a 7-14 membered, bi- or tri-cyclic hetero ring containing one N atom, (10) C3-7 cycloalkyl); R<9> is (1) H, (2) C1-8 alkyl, (3) C7-10 phenylalkyl, (4) C2-10 alkenyl having 1 to 3 double bonds, (5) C2-10 alkynyl having 1 or 2 triple bonds, (6) R<1><1>-COOR<1><2>, (7) C3-7 cycloalkyl;  @  @ is 4-7 membered, mono-cyclic hetero ring containing 1 or 2 N atom; R<1><0> is H, C7-10 phenylalkyl or COOR<1><3>(in which R<1><3> is H, C1-4 alkyl or C7-10 phenylalkyl)); with the proviso that (i) both R<7> and R<8> do not represent hydrogen at the same time, and (ii) when at least one group in R<7>, R<8> and R<9> represents the group containing t-butyl ester, the other groups do not represent the group containing carboxy; or an acid addition salt thereof, have inhibitory activities on PLA2 and on various proteases such as trypsin, plasmin, thrombin, kallikrein, especially trypsin, and are useful for the prevention and/or the treatment of various inflammatory diseases, allergic diseases, disseminated intravascular coagulation, pancreatitis, severity in pancreatitis and multiple organ failure.
Patent DE-69306547-D1 (DE)
Inventor: BENNETT JANE CAROLINE
IPC: A23G1/38
Filed: 1993-03-23
Granted: 1997-01-23
Abstract: The invention concerns blends of fats A, B and C in the ranges: 5-30% of fat A; >60% of fat B; 5-20% of fat C, wherein fat A=fat having a CSAFA: CUNSAT ratio=0.5-1.3; fat B=fat having >65 wt. % of SUS; fat C=butterfat or a fraction therof.
Patent DE-69313871-D1 (DE)
Inventor: HAFNER EDMUND
IPC: A23K20/195
Filed: 1993-12-16
Granted: 1997-10-16
Abstract: An antiparasitic compound of formula (I), (II) or (III) wherein R is selected from a variety of organic groups, the broken line represents an optional double bond, R<1> is H, OH, -O-alkyl or optionally substituted oximino, and R<2> and R<3> are H, OH, H, OMe, oxo, optionally substituted oximino or optionally substituted amino.
Patent DE-69318536-D1 (DE)
Inventor: YANAMOTO KAZUJI
IPC: A23G1/04
Filed: 1993-08-17
Granted: 1998-06-18
Abstract: Raw cacao beans are heated in hot water or water vapor containing an acidic, alkaline or alcoholic substance without being subjected to fermentation or after being slightly fermented, whereby enzymes contained in the beans are inactivated, or microorganisms present on the beans are destroyed, nibs of the beans being thereby prevented from undergoing a color change. This method enables production of white cacao nibs, and it is thus possible to prepare white chocolates and other varieties of food having good flavor and taste by using such cacao nibs.
Patent DE-69326836-D1 (DE)
Inventor: SULLIVAN DAVID A
IPC: C07J1/00
Filed: 1993-04-21
Granted: 1999-11-25
Abstract: The topical application to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutic amount of an androgen or androgen analogue is disclosed as a method of relieving the chronic and acute manifestation of dry eye symptoms in Sj+E,uml o+EE gren's syndrome.
Patent DE-69327531-D1 (DE)
Inventor: WEISSMAN BERNARD
IPC: A61C5/04
Filed: 1993-06-11
Granted: 2000-02-10
Abstract: The invention provides a tubular dental mold form with at least one scalloped end and a method, utilizing the form, for forming a universal crown in situ on a tooth stump. In a preferred form, scalloped edges, of different depths, are formed at both ends and are circumferentially offset on one end with respect to the other end.
Patent DE-69328075-D1 (DE)
Inventor: YASUDA TAKAO
IPC: B60T11/16
Filed: 1993-12-21
Granted: 2000-04-20
Abstract: A control valve assembly for a total pressure hydraulic brake is provided with an input port, an output port, a remote control input port connected to a hydraulic fluid supply means, a first response member which is moved together with depression of a brake pedal, a second response member which is moved by the hydraulic fluid flowing through the remote control input port, and control means which operates in accordance with the movement of either the first or the second response member. The control valve supplies the hydraulic fluid from the input port to the output port in response to the hydraulic fluid flowing through the remote control input port, as well as the depressing force exerted on the brake pedal. <IMAGE>
Patent DE-69401030-D1 (DE)
Inventor: CUINE ALAIN
IPC: A61K35/66
Filed: 1994-05-24
Granted: 1997-01-16
Abstract: Novel medicinal aerosol composition (formulation) based on fusafungine, comprising an excipient chosen from dimethylisosorbide or preferably isopropyl myristate and using 1,1,1,2-tetrafluoroethane as the propellent.
Patent DE-69414331-D1 (DE)
Inventor: DROZ FRANCOIS
IPC: B32B37/18
Filed: 1994-03-14
Granted: 1998-12-10
Abstract: A method for producing a card including at least one electronic component (14), particularly a card having no external contacts and further including a coil (16). According to the method, a structure (10) made of meltable material for positioning the electronic component (14) and the coil (16) is arranged on a work surface (2). By supplying energy, the structure (10) is at least partially melted and pressure is exerted on said melted structure to form a mass in which the electronic component (14) and the coil (16) are embedded.
Patent DE-69424536-D1 (DE)
Inventor: KJELDAHL POUL
IPC: H01R24/64
Filed: 1994-03-11
Granted: 2000-06-21
Abstract: PCT No. PCT/DK94/00107 Sec. 371 Date Sep. 1, 1995 Sec. 102(e) Date Sep. 1, 1995 PCT Filed Mar. 11, 1994 PCT Pub. No. WO94/21007 PCT Pub. Date Sep. 15, 1994A connector plug or jack element for a wire telecommunication system handling data with very high transmission capacity. A linear row of contact terminals is connected to wire connector terminals by leads internal to a cast block member which holds the leads in exact, fixed positions in a spatial or three-dimensional manner.
Patent DE-69425305-D1 (DE)
Inventor: DILL MICHAEL
IPC: C23C14/35
Filed: 1994-09-16
Granted: 2000-08-24
Abstract: Described is a sputtering apparatus and a method employing an auxiliary magnetic structure (11) situated between a substrate holder (5) and a target (4) of a plasma sputtering chamber (20) to control the lateral extent of the plasma. The auxiliary magnetic structure (11), possessing a lower field strength in the plasma region than a principal magnet (14) or magnets, is situated immediately outside of and around a circumference of the chamber's anode shield (10). The principal magnets (14) maintain the plasma in a ring adjacent to the sputtering target. The auxiliary magnet structure (11) causes the plasma ring to expand toward the edge of the target (4) or contract away from the edge depending on the magnetic strength and polarity of the structure and its position relative to the target (4). <IMAGE>
Patent DE-69431052-D1 (DE)
Inventor: DEAN RICHARD T
IPC: A61K103/10
Filed: 1994-04-08
Granted: 2002-08-29
Abstract: PCT No. PCT/US94/03878 Sec. 371 Date Jan. 11, 1996 Sec. 102(e) Date Jan. 11, 1996 PCT Filed Apr. 8, 1994 PCT Pub. No. WO94/23758 PCT Pub. Date Oct. 27, 1994This invention relates to radiolabeled scintigraphic imaging agents, and methods and reagents for producing such agents. Specifically, the invention relates to specific binding compounds, including peptides, that bind to a platelet receptor that is the platelet GPIIb/IIIa receptor, methods and kits for making such compounds, and methods for using such compounds labeled with technetium-99m via a covalently-linked radiolabel-binding moiety to image thrombi in a mammalian body.
Patent DE-69501582-D1 (DE)
Inventor: LARSSON LENNART
IPC: A21B3/04
Filed: 1995-11-06
Granted: 1998-03-12
Abstract: An arrangement for generating steam in ovens, particularly baker's ovens, comprising a stand which carries a plurality of superposed and generally horizontally extending gutter means (8, 9) whose bottoms include a plurality of through-penetrating holes (11) which allow water to pass to underlying gutter means, and further comprising members (12) which are mounted adjacent the holes and which partially covering the holes. The members (12) have an elongated form and extend through holes (11) in at least two gutter means (8, 9) arranged one above the other, and the cross-sectional area of the members (12) in the hole region is smaller than the cross-sectional areas of the gutter means. <IMAGE>
Patent DE-69504332-D1 (DE)
Inventor: WHEATON CHRISTOPHER
IPC: B65D8/04
Filed: 1995-04-20
Granted: 1998-10-01
Abstract: PCT No. PCT/GB95/00890 Sec. 371 Date Oct. 31, 1996 Sec. 102(e) Date Oct. 31, 1996 PCT Filed Apr. 20, 1995 PCT Pub. No. WO95/30585 PCT Pub. Date Nov. 16, 1995A keg (10) for a pressurized fluid is formed of a main body part (11), to respective open ends of which are secured upper and lower ends parts (14, 12), each of the three parts being an injection moulding of thermoplastics material and connected together by welding. Around an internal surface of the main body part (11) is an integral continuous planar flange (21) which serves to resits outwards pressure on the body when the keg is pressurized, in use, the flange defining a large central opening (22) in the interior of the keg. Ribs (25) are formed integrally with the internal body surface and flange, and extend around the flange between respective pairs of first openings (23) through the flange, smaller second openings (24) being aligned with, and disposed at the inner end of the respective ribs.
Patent DE-69510925-D1 (DE)
Inventor: LIOTTA LANCE
IPC: G02B21/32
Filed: 1995-03-01
Granted: 1999-08-26
Abstract: A method of direct extraction of cellular material from a tissue sample which involves: forming an image field of cells of the tissue sample utilizing a microscope, identifying at least one zone of cells of interest from the image field of cells which at least one zone of cells of interest includes different types of cells than adjacent zones of cells, and extracting the at least one zone of cells of interest from the tissue sample. The extracted zone(s) of cells is subjected to analysis. The overall process of identifying, extracting, transporting, and analyzing the extracted zones(s) of cells can be fully automated.
Patent DE-69515318-D1 (DE)
Inventor: AMESTICA ALBERTO
IPC: C11D3/42
Filed: 1995-08-03
Granted: 2000-04-06
Abstract: The performance of photobleaches such as the zinc phthalocyanines is enhanced by means of alkylene amino/carboxylate or alkylene amino/phosphonate chelants. Thus, sulfonated zinc phthalocyanine plus diethylenetriamine pentaacetate provide enhanced photobleaching of laundered fabrics. Detergent compositions comprising the improved photobleach systems are provided.
Patent DE-69517731-D1 (DE)
Inventor: PFEFFERLE WILLIAM C
IPC: F23C9/00
Filed: 1995-04-06
Granted: 2000-08-10
Abstract: Gas phase combustion producing lower emissions in gas turbines is stabilized in a lean pre-mixed combustor, by flow of the fuel/air mixture through a catalyst which is heated by contact with recirculated, partially reacted combustion gases. <IMAGE>
Patent DE-69518425-D1 (DE)
Inventor: HEED BJOERN
IPC: F01N3/28
Filed: 1995-06-13
Granted: 2000-09-21
Abstract: A catalytic purification device for purifying air or gases by heat treatment with a catalyst. The catalyst is carried on a patterned strip (1a) that is folded into a bundle (1b) that forms two groups of parallel flow channels with simple connections (9, 10) for incoming and outgoing flows, and with reversing chamber (8) with heating device (11). Good heat economy is achieved by heat exchange between the incoming and outgoing flows.
Patent DE-69525861-D1 (DE)
Inventor: HORNER ROGER ERIC
IPC: H02K7/02
Filed: 1995-08-02
Granted: 2002-04-18
Abstract: An energy storage and conversion apparatus 1 comprisinga containment 5 defining a vacuum chamber 7,a substantially vertical shaft within the vacuum chamber 7,a stator 11 on the shaft 9, anda cylindrical rotor 13 which, in use, is driven by the stator 11 to store energy as kinetic energy of the rotor 13 and acts with the stator 11 as a generator to release energy,   wherein the rotor 13 is supported by the shaft 9 via an end cap 29, positioned at the upper end of the cylindrical rotor 13, which engages the shaft 9. The rotor 13 is suspended from a pin bearing 31 which is attached to an end cap 29. The pin bearing 31 sits in a bearing cup 37 mounted in a damper 39 at the end of the shaft 9. A magnet bearing 43 is provided at the lower end of the rotor 13 to assist in positioning the rotor 13 relative to the stator 11.
Patent DE-69526882-D1 (DE)
Inventor: BOMBARDELLI EZIO
IPC: C07H17/075
Filed: 1995-07-05
Granted: 2002-07-11
Abstract: The present invention relates to the use of esculoside alone or in combination with adenylate cyclase stimulators, such as forskolin or Salvia miltiorrhiza diterpenes and/or with phosphodiesterase inhibitors, such as apigenine-skeleton dimeric flavones, in topical formulations for the treatment of peripheral vasculopathies related to an impaired peripheral microcirculation, cellulitis or unesthetisms connected with a deposit of superfluous fat. For the reduction of the deposits of superfluous fat of any origin, the above mentioned products are advantageously also combined with caffeine, theophylline and derivatives thereof.
Patent DE-69530974-D1 (DE)
Inventor: GALLIGAN P
IPC: B01J23/54
Filed: 1995-02-14
Granted: 2003-07-10
Abstract: A catalyst composition contains a catalytic material having having an undercoat layer containing a mixture of a fine particulate undercoat refractory metal oxide and a sol such as a silica sol, the undercoat providing good adherence to substrates, such as metal substrates, on which the catalytic material is disposed. An overlayer is coated over the underlayer and contains an overlayer refractory metal oxide, which may be the same as or different from the undercoat refractory metal oxide, and on which is dispersed one or more catalytic metal components, such as palladium and manganese components. The metal substrate may be made of, e.g., aluminum or titanium or alloys thereof, and provides a low pressure drop and lightweight catalyst, making the catalyst especially well adapted for use in aircraft to abate ozone in cabin air. A method of making the catalyst composition includes applying the undercoat to the substrate and calcining it, impregnating the overlayer refractory metal oxide with one or more catalytic metal components and depositing the overlayer over the undercoat, and calcining it.
Patent DE-69534491-D1 (DE)
Inventor: BURR KEITH WILLIAM
IPC: C12R1/19
Filed: 1995-11-15
Granted: 2006-02-09
Abstract: The present invention relates to an enzyme process for the one-step conversion of cephalosporin C or a derivative thereof into 7-aminocephalosporanic acid or a corresponding derivative thereof. The one step conversion is effected using a cephalosphorin C amidohydrolase derived from Pseudomonas Vesicularis B965, or from any cephalosporin C amidolydrolase producing or potentially producing descendants thereof, or from expression of DNA derived from Pseudomonas Vesicularis B965 or any cephalosporin C amidohydrolase producing or potentially producing descendants thereof.
Patent DE-69605531-D1 (DE)
Inventor: CORSI MARCO
IPC: A61K31/221
Filed: 1996-03-04
Granted: 2000-01-13
Abstract: The use of propionyl L-carnitine and pharmacologically acceptable salts thereof is disclosed for producing a medicament for treating chronic arteriosclerosis obliterans which is selectively suited for the treatment of patients with severely disabling intermittent claudication.
Patent DE-69618826-D1 (DE)
Inventor: GEORGANTAS ARISTIDES
IPC: D06B3/28
Filed: 1996-08-10
Granted: 2002-03-14
Abstract: An improved jet dyeing apparatus is provided which enables the user to dye either lightweight or relatively heavy weight fabrics in the same apparatus with improved efficiency and product quality. The apparatus includes a fabric plaiting mechanism mounted to the exit end of a transport tube and a downwardly directed outlet nozzle. The outlet nozzle further includes dye liquor bypass means for withdrawing a portion of the dye liquor outside the primary path of travel of the fabric as the fabric is deposited into the liquid treatment chamber of the apparatus and provision is also made for removing a portion of the liquid from the jet dyeing apparatus and for recycling a portion of the liquid to the suction side of the main recirculating pump. By virtue of this arrangement an improved high efficiency rinse cycle is enabled in accordance with the related method which is also disclosed.
Patent DE-69624346-D1 (DE)
Inventor: GETMAN P
IPC: A61P31/18
Filed: 1996-03-07
Granted: 2002-11-21
Abstract: Selected amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
Patent DE-69635656-D1 (DE)
Inventor: SCHINAZI F
IPC: A61K31/7068
Filed: 1996-01-29
Granted: 2006-02-02
Abstract: A method and composition for the treatment of HIV and HBV infections in humans and other host animals is disclosed that includes the administration of an effective amount of a Ä5-carboxamido or 5-fluoroÜ-2',3'-dideoxy-2',3'-didehydro-pyrimidine nucleoside or a Ä5-carboxamido or 5-fluoroÜ-3'-modified-pyrimidine nucleoside, mixtures thereof, or a pharmaceutically acceptable derivative or derivatives thereof, including an N-1 or N-4 alkylated or acylated derivative, or a pharmaceutically acceptable salt thereof, in a pharmaceutically acceptable carrier.